BioVie Inc.
BIVI
$1.64
$0.052.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.80% | 50.16% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 44.27% | 22.59% | |||
| Operating Income | -44.27% | -22.59% | |||
| Income Before Tax | -45.81% | -25.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -45.81% | -25.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.81% | -25.13% | |||
| EBIT | -44.27% | -22.59% | |||
| EBITDA | -44.97% | -23.02% | |||
| EPS Basic | 47.59% | -24.61% | |||
| Normalized Basic EPS | 48.03% | -24.60% | |||
| EPS Diluted | 47.59% | -24.61% | |||
| Normalized Diluted EPS | 48.03% | -24.60% | |||
| Average Basic Shares Outstanding | 180.59% | 0.42% | |||
| Average Diluted Shares Outstanding | 180.59% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||